{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:28:02Z","timestamp":1790526482084,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The amino-acids tryptophan, phenylalanine and tyrosine seem to play an important role in the pathophysiology of depressive disorders. We measured daily brain extracellular levels of these amino-acids using cerebral microdialysis (CMD) and high performance liquid chromatography in 26 consecutive subarachnoid hemorrhage (SAH) patients and associated them with the presence of depressive disorders. Patients were grouped as follows: medical history of depression (prior to SAH), antidepressant intake 12 months after SAH (but not before), or neither. CMD-tryptophan, CMD-phenylalanine and CMD-tyrosine levels were significantly lower in patients with preexisting depressive disorders compared to those without depression (p\u2009&lt;\u20090.01). Disease severity and SAH-related complications were not associated with amino-acid concentrations. We found a positive correlation between nutritionally administered and brain interstitial levels of tryptophan and phenylalanine in non-depressed patients (R\u2009=\u20090.26 and R\u2009=\u20090.24, p\u2009&lt;\u20090.05), which was not present in patients with preexisting depression (p\u2009&gt;\u20090.1). In conclusion, brain interstitial levels of tryptophan, phenylalanine and tyrosine measured in the context of the clinical management of SAH were significantly decreased in patients with a medical history of depression. This study supports the hypothesis that the availability of these neurotransmitter precursor amino-acids in the human brain may play an important role in the pathophysiology of depressive disorders.<\/jats:p>","DOI":"10.1038\/s41598-019-39569-5","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T11:49:58Z","timestamp":1551181798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["A reduced concentration of brain interstitial amino acids is associated with depression in subarachnoid hemorrhage patients"],"prefix":"10.1038","volume":"9","author":[{"given":"Mario","family":"Kofler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alois Josef","family":"Schiefecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Gaasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sperner-Unterweger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1627-9563","authenticated-orcid":false,"given":"Dietmar","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Ferger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Rass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Hackl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rhomberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Pfausler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius","family":"Thom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Schmutzhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimund","family":"Helbok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,26]]},"reference":[{"key":"39569_CR1","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1161\/STROKEAHA.108.191395","volume":"40","author":"JB Bederson","year":"2009","unstructured":"Bederson, J. B. et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40, 994\u20131025, https:\/\/doi.org\/10.1161\/STROKEAHA.108.191395 (2009).","journal-title":"Stroke"},{"key":"39569_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1474-4422(09)70126-7","volume":"8","author":"DJ Nieuwkamp","year":"2009","unstructured":"Nieuwkamp, D. J. et al. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. The Lancet. Neurology 8, 635\u2013642, https:\/\/doi.org\/10.1016\/S1474-4422(09)70126-7 (2009).","journal-title":"The Lancet. Neurology"},{"key":"39569_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1474-4422(11)70017-5","volume":"10","author":"GJ Rinkel","year":"2011","unstructured":"Rinkel, G. J. & Algra, A. Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. The Lancet. Neurology 10, 349\u2013356, https:\/\/doi.org\/10.1016\/S1474-4422(11)70017-5 (2011).","journal-title":"The Lancet. Neurology"},{"key":"39569_CR4","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.1161\/STROKEAHA.110.581975","volume":"41","author":"T Al-Khindi","year":"2010","unstructured":"Al-Khindi, T., Macdonald, R. L. & Schweizer, T. A. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke 41, e519\u2013536, https:\/\/doi.org\/10.1161\/STROKEAHA.110.581975 (2010).","journal-title":"Stroke"},{"key":"39569_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.23736\/S1973-9087.16.04202-7","volume":"53","author":"PY Ackermark","year":"2017","unstructured":"Ackermark, P. Y. et al. Longitudinal course of depressive symptoms and anxiety after aneurysmal subarachnoid hemorrhage. European journal of physical and rehabilitation medicine 53, 98\u2013104, https:\/\/doi.org\/10.23736\/S1973-9087.16.04202-7 (2017).","journal-title":"European journal of physical and rehabilitation medicine"},{"key":"39569_CR6","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1161\/STROKEAHA.116.014327","volume":"47","author":"J Huttunen","year":"2016","unstructured":"Huttunen, J. et al. Antidepressant Use After Aneurysmal Subarachnoid Hemorrhage: A Population-Based Case-Control Study. Stroke 47, 2242\u20132248, https:\/\/doi.org\/10.1161\/STROKEAHA.116.014327 (2016).","journal-title":"Stroke"},{"key":"39569_CR7","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1161\/STROKEAHA.108.531277","volume":"40","author":"JM Visser-Meily","year":"2009","unstructured":"Visser-Meily, J. M., Rhebergen, M. L., Rinkel, G. J., van Zandvoort, M. J. & Post, M. W. Long-term health-related quality of life after aneurysmal subarachnoid hemorrhage: relationship with psychological symptoms and personality characteristics. Stroke 40, 1526\u20131529, https:\/\/doi.org\/10.1161\/STROKEAHA.108.531277 (2009).","journal-title":"Stroke"},{"key":"39569_CR8","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3109\/02688697.2011.578769","volume":"25","author":"M Hedlund","year":"2011","unstructured":"Hedlund, M., Zetterling, M., Ronne-Engstrom, E., Carlsson, M. & Ekselius, L. Depression and post-traumatic stress disorder after aneurysmal subarachnoid haemorrhage in relation to lifetime psychiatric morbidity. British journal of neurosurgery 25, 693\u2013700, https:\/\/doi.org\/10.3109\/02688697.2011.578769 (2011).","journal-title":"British journal of neurosurgery"},{"key":"39569_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jns.2013.08.024","volume":"335","author":"KT Kreiter","year":"2013","unstructured":"Kreiter, K. T. et al. Depressed mood and quality of life after subarachnoid hemorrhage. Journal of the neurological sciences 335, 64\u201371, https:\/\/doi.org\/10.1016\/j.jns.2013.08.024 (2013).","journal-title":"Journal of the neurological sciences"},{"key":"39569_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJMra073096","volume":"358","author":"RH Belmaker","year":"2008","unstructured":"Belmaker, R. H. & Agam, G. Major depressive disorder. The New England journal of medicine 358, 55\u201368, https:\/\/doi.org\/10.1056\/NEJMra073096 (2008).","journal-title":"The New England journal of medicine"},{"key":"39569_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/7854_2016_23","volume":"31","author":"B Strasser","year":"2017","unstructured":"Strasser, B., Sperner-Unterweger, B., Fuchs, D. & Gostner, J. M. Mechanisms of Inflammation-Associated Depression: Immune Influences on Tryptophan and Phenylalanine Metabolisms. Current topics in behavioral neurosciences 31, 95\u2013115, https:\/\/doi.org\/10.1007\/7854_2016_23 (2017).","journal-title":"Current topics in behavioral neurosciences"},{"key":"39569_CR12","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2174\/1381612822666151215102420","volume":"22","author":"G Morris","year":"2016","unstructured":"Morris, G., Carvalho, A. F., Anderson, G., Galecki, P. & Maes, M. The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders. Current pharmaceutical design 22, 963\u2013977 (2016).","journal-title":"Current pharmaceutical design"},{"key":"39569_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.biopsych.2010.12.006","volume":"70","author":"L Capuron","year":"2011","unstructured":"Capuron, L. et al. Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biological psychiatry 70, 175\u2013182, https:\/\/doi.org\/10.1016\/j.biopsych.2010.12.006 (2011).","journal-title":"Biological psychiatry"},{"key":"39569_CR14","doi-asserted-by":"publisher","unstructured":"Zetterling, M. et al. Temporal patterns of interstitial pyruvate and amino acids after subarachnoid haemorrhage are related to the level of consciousness\u2013a clinical microdialysis study. Acta neurochirurgica 151, 771\u2013780; discussion 780, https:\/\/doi.org\/10.1007\/s00701-009-0384-4 (2009).","DOI":"10.1007\/s00701-009-0384-4"},{"key":"39569_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/jnnp.72.1.99","volume":"72","author":"PJ Hutchinson","year":"2002","unstructured":"Hutchinson, P. J. et al. Increases in GABA concentrations during cerebral ischaemia: a microdialysis study of extracellular amino acids. Journal of neurology, neurosurgery, and psychiatry 72, 99\u2013105 (2002).","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"key":"39569_CR16","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/hs0901.095677","volume":"32","author":"J Claassen","year":"2001","unstructured":"Claassen, J. et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke 32, 2012\u20132020 (2001).","journal-title":"Stroke"},{"key":"39569_CR17","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1161\/01.STR.0000015624.29071.1F","volume":"33","author":"J Claassen","year":"2002","unstructured":"Claassen, J. et al. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke 33, 1225\u20131232 (2002).","journal-title":"Stroke"},{"key":"39569_CR18","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1161\/01.STR.21.8.1156","volume":"21","author":"A Hijdra","year":"1990","unstructured":"Hijdra, A., Brouwers, P. J., Vermeulen, M. & van Gijn, J. Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke 21, 1156\u20131161 (1990).","journal-title":"Stroke"},{"key":"39569_CR19","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly Jr.","year":"2012","unstructured":"Connolly, E. S. Jr. et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/american Stroke Association. Stroke 43, 1711\u20131737, https:\/\/doi.org\/10.1161\/STR.0b013e3182587839 (2012).","journal-title":"Stroke"},{"key":"39569_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000346087","volume":"35","author":"T Steiner","year":"2013","unstructured":"Steiner, T. et al. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovascular diseases 35, 93\u2013112, https:\/\/doi.org\/10.1159\/000346087 (2013).","journal-title":"Cerebrovascular diseases"},{"key":"39569_CR21","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","volume":"41","author":"MD Vergouwen","year":"2010","unstructured":"Vergouwen, M. D. et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 41, 2391\u20132395, https:\/\/doi.org\/10.1161\/STROKEAHA.110.589275 (2010).","journal-title":"Stroke"},{"key":"39569_CR22","doi-asserted-by":"publisher","first-page":"e906","DOI":"10.4088\/JCP.13r08908","volume":"75","author":"S Ogawa","year":"2014","unstructured":"Ogawa, S. et al. Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis. The Journal of clinical psychiatry 75, e906\u2013915, https:\/\/doi.org\/10.4088\/JCP.13r08908 (2014).","journal-title":"The Journal of clinical psychiatry"},{"key":"39569_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0893-133X(97)00198-X","volume":"19","author":"LL Carpenter","year":"1998","unstructured":"Carpenter, L. L. et al. Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 19, 26\u201335, https:\/\/doi.org\/10.1016\/S0893-133X(97)00198-X (1998).","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"key":"39569_CR24","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/sj.npp.1300098","volume":"28","author":"RM Salomon","year":"2003","unstructured":"Salomon, R. M. et al. Association of a critical CSF tryptophan threshold level with depressive relapse. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 28, 956\u2013960, https:\/\/doi.org\/10.1038\/sj.npp.1300098 (2003).","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"key":"39569_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.euroneuro.2009.10.003","volume":"20","author":"FA Moreno","year":"2010","unstructured":"Moreno, F. A. et al. CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology 20, 18\u201324, https:\/\/doi.org\/10.1016\/j.euroneuro.2009.10.003 (2010).","journal-title":"European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology"},{"key":"39569_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/mp.2009.116","volume":"15","author":"CL Raison","year":"2010","unstructured":"Raison, C. L. et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Molecular psychiatry 15, 393\u2013403, https:\/\/doi.org\/10.1038\/mp.2009.116 (2010).","journal-title":"Molecular psychiatry"},{"key":"39569_CR27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/jnnp.38.4.322","volume":"38","author":"SN Young","year":"1975","unstructured":"Young, S. N. et al. Relationships between tryptophan in serum and CSF, and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration. Journal of neurology, neurosurgery, and psychiatry 38, 322\u2013330 (1975).","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"key":"39569_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.psyneuen.2015.06.001","volume":"60","author":"K Hufner","year":"2015","unstructured":"Hufner, K. et al. Levels in neurotransmitter precursor amino acids correlate with mental health in patients with breast cancer. Psychoneuroendocrinology 60, 28\u201338, https:\/\/doi.org\/10.1016\/j.psyneuen.2015.06.001 (2015).","journal-title":"Psychoneuroendocrinology"},{"key":"39569_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbi.2012.10.010","volume":"31","author":"JC Felger","year":"2013","unstructured":"Felger, J. C. et al. Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations. Brain, behavior, and immunity 31, 153\u2013160, https:\/\/doi.org\/10.1016\/j.bbi.2012.10.010 (2013).","journal-title":"Brain, behavior, and immunity"},{"key":"39569_CR30","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller, A. H., Maletic, V. & Raison, C. L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological psychiatry 65, 732\u2013741, https:\/\/doi.org\/10.1016\/j.biopsych.2008.11.029 (2009).","journal-title":"Biological psychiatry"},{"key":"39569_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.pnpbp.2012.10.006","volume":"48","author":"B Sperner-Unterweger","year":"2014","unstructured":"Sperner-Unterweger, B., Kohl, C. & Fuchs, D. Immune changes and neurotransmitters: possible interactions in depression? Progress in neuro-psychopharmacology & biological psychiatry 48, 268\u2013276, https:\/\/doi.org\/10.1016\/j.pnpbp.2012.10.006 (2014).","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"key":"39569_CR32","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/archpsyc.1981.01780310042003","volume":"38","author":"MK DeMyer","year":"1981","unstructured":"DeMyer, M. K., Shea, P. A., Hendrie, H. C. & Yoshimura, N. N. Plasma tryptophan and five other amino acids in depressed and normal subjects. Archives of general psychiatry 38, 642\u2013646 (1981).","journal-title":"Archives of general psychiatry"},{"key":"39569_CR33","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/S0140-6736(84)91648-9","volume":"2","author":"B Woggon","year":"1984","unstructured":"Woggon, B., Angst, J., Curtius, H. C. & Niederwieser, A. Unsuccessful treatment of depression with tetrahydrobiopterin. Lancet 2, 1463 (1984).","journal-title":"Lancet"},{"key":"39569_CR34","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/archpsyc.63.11.1209","volume":"63","author":"JH Meyer","year":"2006","unstructured":"Meyer, J. H. et al. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Archives of general psychiatry 63, 1209\u20131216, https:\/\/doi.org\/10.1001\/archpsyc.63.11.1209 (2006).","journal-title":"Archives of general psychiatry"},{"key":"39569_CR35","doi-asserted-by":"publisher","first-page":"12079","DOI":"10.1073\/pnas.96.21.12079","volume":"96","author":"RJ Boado","year":"1999","unstructured":"Boado, R. J., Li, J. Y., Nagaya, M., Zhang, C. & Pardridge, W. M. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proceedings of the National Academy of Sciences of the United States of America 96, 12079\u201312084 (1999).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"39569_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1602\/neurorx.2.1.54","volume":"2","author":"A Tsuji","year":"2005","unstructured":"Tsuji, A. Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems. NeuroRx: the journal of the American Society for Experimental NeuroTherapeutics 2, 54\u201362, https:\/\/doi.org\/10.1602\/neurorx.2.1.54 (2005).","journal-title":"NeuroRx: the journal of the American Society for Experimental NeuroTherapeutics"},{"key":"39569_CR37","first-page":"1183","volume":"19","author":"F Niklasson","year":"1984","unstructured":"Niklasson, F. & Agren, H. Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood. Biological psychiatry 19, 1183\u20131206 (1984).","journal-title":"Biological psychiatry"},{"key":"39569_CR38","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3171\/2009.1.JNS08587","volume":"111","author":"A Nagel","year":"2009","unstructured":"Nagel, A. et al. Relevance of intracranial hypertension for cerebral metabolism in aneurysmal subarachnoid hemorrhage. Clinical article. Journal of neurosurgery 111, 94\u2013101, https:\/\/doi.org\/10.3171\/2009.1.JNS08587 (2009).","journal-title":"Clinical article. Journal of neurosurgery"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39569-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39569-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39569-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T06:38:52Z","timestamp":1671259132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-39569-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,26]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["39569"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-39569-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,26]]},"assertion":[{"value":"7 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2811"}}